NAGOYA CITY UNIVERSITY IMAGE: THE INFLUX OF CA2+ INTO VASCULAR SMOOTH MUSCLE CELLS THROUGH CAV1.2 WITHIN CAVEOLAE DUE TO HYPERTENSION ACTIVATES A PATHWAY LEADING TO INFLAMMATION AND VASCULAR REMODELING. THIS, IN TURN, CAUSES ARTERIOSCLEROSIS. THE CAMKK2 PROTEIN IS A POTENTIAL DRUG TARGET TO PREVENT THIS PROCESS. CREDIT: YOSHIAKI SUZUKI FROM NCU, JAPAN PROCEEDINGS OF THE...
LUND UNIVERSITY Diabetes is currently treated using incretin hormones to reduce the risk of cardiovascular disease and other medical issues that the illness can trigger. Now researchers from Lund University in Sweden have noted new links between these hormones and arteriosclerosis, and believe their discovery could be significant for treatment of diabetes in the future. The study...
